These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36118651)

  • 1. Screening for head and neck tumors in patients with esophageal squamous cell carcinoma and vice versa: a nationwide survey among medical specialists.
    van Tilburg L; van den Ban SA; van de Ven SEM; Sewnaik A; Bruno MJ; Spaander MCW; Baatenburg de Jong RJ; Koch AD
    Endosc Int Open; 2022 Sep; 10(9):E1268-E1274. PubMed ID: 36118651
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of lung tumors in patients with esophageal squamous cell carcinoma and vice versa: a systematic review and meta-analysis.
    van Tilburg L; van de Ven SEM; Spaander MCW; van Kleef LA; Cornelissen R; Bruno MJ; Koch AD
    J Cancer Res Clin Oncol; 2023 May; 149(5):1811-1823. PubMed ID: 35737094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for head and neck second primary tumors in patients with esophageal squamous cell cancer: A systematic review and meta-analysis.
    van de Ven S; Bugter O; Hardillo JA; Bruno MJ; Baatenburg de Jong RJ; Koch AD
    United European Gastroenterol J; 2019 Dec; 7(10):1304-1311. PubMed ID: 31839955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for synchronous esophageal second primary tumors in patients with head and neck cancer.
    van de Ven SEM; de Graaf W; Bugter O; Spaander MCW; Nikkessen S; de Jonge PJF; Hardillo JA; Sewnaik A; Monserez DA; Mast H; Keereweer S; Bruno MJ; Baatenburg de Jong RJ; Koch AD
    Dis Esophagus; 2021 Oct; 34(10):. PubMed ID: 34075402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of routine esophageal screening in patients with head and neck cancer.
    Su YY; Chen WC; Chuang HC; Guo CS; Lin YT; Luo SD; Fang FM; Chien CY
    JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):350-4. PubMed ID: 23519755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
    Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
    World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal Second Primary Tumors in Patients With Head and Neck Squamous Cell Carcinoma: Incidence, Risk Factors, and Overall Survival.
    Overwater A; Rueb K; Elias SG; de Bree R; Weusten BLAM
    Am J Gastroenterol; 2022 May; 117(5):794-797. PubMed ID: 35213400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
    Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL
    Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic Screening for Second Primary Tumors of the Esophagus Among Head and Neck Cancer Patients.
    Chung CS; Liao LJ; Wu CY; Lo WC; Hsieh CH; Lee TH; Liu CY; Kuo DY; Shueng PW
    Front Oncol; 2022; 12():906125. PubMed ID: 35747824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of second head and neck tumors in primary laryngeal SCC is an indicator of overall survival and not associated with poorer overall survival: a single centre study in 987 patients.
    Farhadieh RD; Salardini A; Yang JL; Russell P; Smee R
    J Surg Oncol; 2010 Jan; 101(1):72-7. PubMed ID: 19798688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Esophageal Squamous Cell Carcinoma in Patients with Head and Neck Squamous Cell Carcinoma.
    Wang L; Pang W; Zhou K; Li L; Wang F; Cao W; Meng X
    J Oncol; 2022; 2022():5227771. PubMed ID: 36065312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.
    Chen YH; Lu HI; Chien CY; Lo CM; Wang YM; Chou SY; Su YY; Shih LH; Li SH
    Sci Rep; 2017 Jan; 7():41785. PubMed ID: 28134308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No evidence of HPV DNA in esophageal squamous cell carcinoma in a population of Southern Brazil.
    Antunes LC; Prolla JC; de Barros Lopes A; da Rocha MP; Fagundes RB
    World J Gastroenterol; 2013 Oct; 19(39):6598-603. PubMed ID: 24151387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis.
    Bugter O; van de Ven SEM; Hardillo JA; Bruno MJ; Koch AD; Baatenburg de Jong RJ
    Head Neck; 2019 Apr; 41(4):1122-1130. PubMed ID: 30593712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal relationship of synchronous head and neck cancer and esophageal cancer assessed by single nucleotide polymorphism-based loss of heterozygosity analysis.
    Sunpaweravong S; Bunbanjerdsuk S; Pongrujikorn T; Naktang C; Sunpaweravong P; Nitiruangjaras A; Dechaphankul T; Jinawath N
    BMC Cancer; 2019 Dec; 19(1):1174. PubMed ID: 31795956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability and efficacy of durvalumab, either as monotherapy or in combination with tremelimumab, in patients from Asia with advanced biliary tract, esophageal, or head-and-neck cancer.
    Doki Y; Ueno M; Hsu CH; Oh DY; Park K; Yamamoto N; Ioka T; Hara H; Hayama M; Nii M; Komuro K; Sugimoto M; Tahara M
    Cancer Med; 2022 Jul; 11(13):2550-2560. PubMed ID: 35611499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does a history of head and neck cancer affect outcome of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma?
    Moura RN; Arantes VN; Ribeiro TML; Guimarães RG; de Oliveira JF; Kulcsar MAV; Sallum RAA; Ribeiro-Junior U; Maluf-Filho F
    Endosc Int Open; 2020 Jul; 8(7):E900-E910. PubMed ID: 32617394
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma.
    Fukuhara T; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
    J Clin Gastroenterol; 2010 Feb; 44(2):e27-33. PubMed ID: 19730116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma.
    Katada C; Muto M; Nakayama M; Tanabe S; Higuchi K; Sasaki T; Azuma M; Ishido K; Katada N; Yamashita K; Nemoto M; Shibata T; Masaki T; Okamoto M; Koizumi W
    Laryngoscope; 2012 Jun; 122(6):1291-6. PubMed ID: 22674532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.